Login

Amgen commits $1 billion for North Carolina expansion, sets up state's latest high-profile pharmaceutical project

Global biopharmaceutical company expects to create 370 jobs with new plant in Holly Springs
An aerial view of the first of Amgen’s drug manufacturing plants in Holly Springs, North Carolina, which is nearing completion. (CoStar)
An aerial view of the first of Amgen’s drug manufacturing plants in Holly Springs, North Carolina, which is nearing completion. (CoStar)
CoStar Analytics
December 6, 2024 | 5:44 P.M.

A global biopharmaceutical company is investing $1 billion in a new drug manufacturing plant in greater Raleigh, North Carolina, the latest in a run of high-profile pharmaceutical projects in one of the top life sciences markets in the country.

This news story is available exclusively to CoStar subscribers.

Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.

This news story is available exclusively to CoStar subscribers.

Ready to Learn More?

Sign Up For a Personalized Demo.

Sign Up For a Demo To Learn More.

Already A Subscriber? Sign In

IN THIS ARTICLE